COMMISSION REGULATION (EC) No 480/97 of 14 March 1997 amending Annex I to Council Regulation (EEC) No 2658/87 on the tariff and statistical nomenclature and on the Common Customs Tariff

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Regulation (EEC) No 2658/87 of 23 July 1987 on the tariff and statistical nomenclature and on the Common Customs Tariff (1), as last amended by Commission Regulation (EC) No 288/97 (2), and in particular Articles 9 and 12 thereof,

Whereas, in the Uruguay Round talks, specified pharmaceutical products were to a certain extent granted exemption from customs duties; whereas the first review of the agreements relating to such products has now taken place within the WTO;

Whereas, accordingly, Council Regulation (EC) No 467/97 (3) provides for duty-free treatment for certain active ingredients bearing an 'international non-proprietary name` (INN) from the World Health Organization and for certain products used for the manufacture of finished pharmaceuticals; whereas it also provides for the withdrawal of duty-free treatment as pharmaceutical products from certain INN products whose use is predominantly non-pharmaceutical;

Whereas these amendments should be incorporated into Annex I to Council Regulation (EEC) No 2658/87;

Whereas the measures provided for in this Regulation are in accordance with the opinion of the Tariff and Statistical Nomenclature Section of the Customs Code Committee,

HAS ADOPTED THIS REGULATION:

Article 1

Annex I, Part Two, to Council Regulation (EEC) No 2658/87 is hereby amended in accordance with Annex I to this Regulation.

Article 2

Annex I, Part Three, Section II, to Council Regulation (EEC) No 2658/87 is hereby amended as follows:

1. the products included in Annex II to this Regulation shall be added to Annex 3;

2. the products included in Annex III to this Regulation shall be deleted from Annex 3;

3. the products included in Annex IV to this Regulation shall be added to Annex 4;

4. the products included in Annex V to this Regulation shall be added to Annex 6.

Article 3

This Regulation shall enter into force on the third day following its publication in the Official Journal of the European Communities.

It shall apply from 1 April 1997.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 14 March 1997.

For the Commission

Mario MONTI

Member of the Commission

(1) OJ No L 256, 7. 9. 1987, p. 1.

(2) OJ No L 48, 19. 2. 1997, p. 7.

(3) OJ No L 71, 13. 3. 1997, p. 1.

ANNEX I

>TABLE>

ANNEX II

List of international non-proprietary names (INNs) to be added to the list of products receiving duty-free treatment included in Annex 3 to Regulation (EEC) No 2658/87

>TABLE>

ANNEX III

List of international non-proprietary names (INNs) to be deleted from the list of products receiving duty-free treatment included in Annex 3 to Regulation (EEC) No 2658/87

>

TABLE POSITION>

ANNEX IV

List of prefixes and suffixes which, in combination with the INNs, describe the salts, esters or hydrates of INNs, to be added to Annex 4 to Regulation (EEC) No 2658/87

ACETURATE

N-ACETYLGLYCINATE

ACISTRATE

ACOXIL

AMSONATE

BENZATHINE

BENZENESULPHONATE

BEZOMIL

BUCICLATE

BUNAPSILATE

BUTEPRATE

tert-BUTYL

tertiary BUTYL

t-BUTYLAMINE

tertiary BUTYLAMINE

BUTYL ESTER

CAMPHORSULPHONATE

CAMPHOR-10-SULPHONATE

CARBESILATE

p-CHLOROBENZENESULFONATE

p-CHLOROBENZENESULPHONATE

CICLOTATE

CIPIONATE

CLOSILATE

CLOSYLATE

CROBEFATE

CROMACATE

CROMESILATE

N-CYCLOHEXYLSULFAMATE

CYCLOPENTANEPROPIONATE

CYCLOTATE

CYPIONATE

DAPROPATE

DEANIL

DECIL

DIBUDINATE

DIBUNATE

DIETHANOLAMINE

DIGOLIL

N,N-DIMETHYL-beta-ALANINE

DIOLAMINE

DISULPHATE

DISULPHIDE

DOCOSIL

DOFOSFATE

EDAMINE

EDISYLATE

EPOLAMINE

ERBUMINE

ETABONATE

1,2-ETHANEDISULPHONATE

ETHANESULPHONATE

ETHANOLAMINE

ETHYLENEDIAMINE

FARNESIL

FENDIZOATE

FLUOROSULPHONATE

FOSTEDATE

HEMISULPHATE

HIBENZATE

HYBENZATE

HYCLATE

HYDROGEN SULPHATE

HYDROGEN SULPHITE

o-(4-HYDROXYBENZOYL)BENZOATE

2-HYDROXYETHANESULPHONATE

ISOCAPROATE

LAURIL

LAURILSULFATE

LAURILSULPHATE

LAURYL

LAURYLSULFATE

LAURYLSULPHATE

MEGALLATE

METEMBONATE

METHANESULPHONATE

4-METHYLBICYCLO [2.2.2] OCT-2-ENE-1-

CARBOXYLATE

METILSULFATE

METILSULPHATE

MOFETIL

OCTIL

OLAMINE

OXOGLURATE

1,5-NAPHTHALENEDISULPHONATE

2-NAPHTHALENESULPHONATE

PANTOTHENATE SULPHATE

PENDETIDE

PIVOXETIL

POTASSIUM SULPHATE

PROPIONATE DODECYL SULFATE

PROPIONATE LAURYL SULPHATE

PROXETIL

1-PYRROLIDINEETHANOL

SODIUM LAURIL SULFATE

SODIUM LAURIL SULPHATE

SODIUM LAURYL SULFATE

SODIUM LAURYL SULPHATE

SODIUM METHANESULFONATE

SODIUM 3-SULFOBENZOATE

SODIUM SULPHOBENZOATE

STEAGLATE

SULPHINATE

SULPHITE

TENOATE

TEPROSILATE

TETRADECYL HYDROGEN PHOSPHATE

TOFESILATE

p-TOLUENESULPHONATE

TRICOFENATE

TRIETHANOLAMINE

TRIFLUTATE

TROLAMINE

TROMETAMOL

TROMETHAMINE

TROXUNDATE

XINAFOATE

ANNEX V

List of pharmaceutical intermediates, i.e. compounds used for the manufacture of finished pharmaceutical products, to be added to the list of products receiving duty free treatment included in Annex 6 to Regulation (EEC) No 2658/87

>TABLE>